Press Release
Home > Press Release > PR Newswire
WuXi PharmaTech to Present at 27th Annual J.P. Morgan Healthcare Conference
Font Scale: 
SHANGHAI, China, Jan. 6 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc.(NYSE: WX), a leading pharmaceutical, biotechnology, and medical deviceresearch and development outsourcing company with operations in China and theUnited States, today announced that Dr. Ge Li, the Company's Chairman andChief Executive Officer, will present at the 27th Annual J.P. MorganHealthcare Conference on Tuesday, January 13, 2009, at 4:30 pm PacificStandard Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The Company will broadcast its presentation. The public may access thebroadcast through the Investor Relations section of the Company's web site:http://www.wuxiapptec.com .
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medicaldevice R&D outsourcing company, with operations in China and the United States.As a research-driven and customer-focused company, WuXi PharmaTech provides abroad and integrated portfolio of laboratory and manufacturing servicesthroughout the drug and medical device R&D process. WuXi PharmaTech'sservices are designed to assist its global partners in shortening the cycleand lowering the cost of drug and medical device R&D. WuXi PharmaTech'soperating subsidiaries are known as WuXi AppTec. For more information, pleasevisit: http://www.wuxiapptec.com .
For more information, please contact: Ronald Aldridge Director of Investor Relations WuXi PharmaTech (Cayman) Inc. Tel: +1-215-218-5515 Email: Ron_Aldridge@wuxiapptec.com Juliane Snowden Vice President of Investor Relations Burns McClellan Tel: +1-212-213-0006 Email: Jsnowden@burnsmc.com Web: http://www.wuxiapptec.comSOURCE WuXi PharmaTech (Cayman) Inc.
The Company will broadcast its presentation. The public may access thebroadcast through the Investor Relations section of the Company's web site:http://www.wuxiapptec.com .
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medicaldevice R&D outsourcing company, with operations in China and the United States.As a research-driven and customer-focused company, WuXi PharmaTech provides abroad and integrated portfolio of laboratory and manufacturing servicesthroughout the drug and medical device R&D process. WuXi PharmaTech'sservices are designed to assist its global partners in shortening the cycleand lowering the cost of drug and medical device R&D. WuXi PharmaTech'soperating subsidiaries are known as WuXi AppTec. For more information, pleasevisit: http://www.wuxiapptec.com .
For more information, please contact: Ronald Aldridge Director of Investor Relations WuXi PharmaTech (Cayman) Inc. Tel: +1-215-218-5515 Email: Ron_Aldridge@wuxiapptec.com Juliane Snowden Vice President of Investor Relations Burns McClellan Tel: +1-212-213-0006 Email: Jsnowden@burnsmc.com Web: http://www.wuxiapptec.comSOURCE WuXi PharmaTech (Cayman) Inc.
For more iinformation, go to www.prnewswire.com
- Sponsored By
-
Recent Press Release
Advertisement
POS Magnetic Card Readers
Online distributor for point of sale equipment, TYSSO and Pegasus.
